27 結果查獲. 排序依照 相關性 | 日期 | 書名 .
Record:   Prev Next
作者 Carreyrou, John, author
書名 Bad blood : secrets and lies in a Silicon Valley startup / John Carreyrou
出版項 New York : Alfred A. Knopf, a division of Penguin Random House LLC, 2018
國際標準書號 9781524731656 (hardback)
9781524731663 (ebook)
book jacket
館藏地 索書號 處理狀態 OPAC 訊息 條碼
 人文社會聯圖  HD9995.H423 U627 2018    到期 04-03-19    30610020582748
 人社中心  HD9995.H423 U627 2018    新書展示中    30560400647761
版本 First Edition
說明 x, 341 pages ; 25 cm
text txt rdacontent
unmediated n rdamedia
volume nc rdacarrier
附註 Includes bibliographical references (pages 305-324) and index
"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"-- Provided by publisher
主題 Theranos (Firm) -- History
Hematologic equipment industry -- United States
Fraud -- United States
BUSINESS & ECONOMICS / Entrepreneurship. bisacsh
BUSINESS & ECONOMICS / Finance. bisacsh
TECHNOLOGY & ENGINEERING / Biomedical. bisacsh
Record:   Prev Next